Evaxion Share Price

Evaxion Share Price

NASDAQ: EVAX | Others
$2.07
-$0.47 (-18.5%) Last updated on 20 Nov, 2026 | 02:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Evaxion Stock Performance

Open
$2.51
Prev. Close
$2.54
Circuit Range
N/A
Day Range
$2.07 - $2.51
Year Range
$2.07 - $6.84
Volume
2,774
Average Traded
$2.30

Evaxion Share Price Today

As of 20 November 2026, Evaxion A/S's share price is $2.07. The stock opened at $2.51, compared to its previous close of $2.54. During today's trading session, Evaxion A/S's share price traded between $2.07 and $2.51, with an average price of $2.29. Over the past 52 weeks, the stock has recorded a high of $6.84 and a low of $2.07. In terms of performance, Evaxion A/S's share price has declined by 49.76% over the last six months and is down 65.50% on a year-on-year basis.

Evaxion Share Price Chart

Line chart of the Evaxion price trend over the selected period. The price fell overall, ranging from 2.44 to 2.74, ending at 2.54.
$2.07$2.51
L
Show Current Price
H

Evaxion Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$7.53B
Return On Equity (TTM)
N/A
Profit Margin
-102.39%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Evaxion Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.07$3.34$7.53
Net Profit-$23.17-$22.13-$10.57-$7.71
Net Profit MarginN/A-31614.29%-316.47%-102.39%
Income ChangeN/A4.49%52.24%27.06%

Evaxion Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets3.513.724.545.04
Current Assets24.98.778.3516.99
Total Assets28.4112.4912.8922.03
Non Current Liabilities7.119.7710.539.96
Current Liabilities4.264.377.083.76
Total Liabilities11.3714.1417.6213.72
Shareholders' Equity17.04-1.65-4.738.3

Evaxion Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-6.63-12.94-17.69-25.77
Investing-0.010.0-0.09-0.27
Financing22.4113.1310.697.85

Corporate Actions

Split
Ex-date: 14 Jan 2025

Split
Ex-date: 22 Jan 2024

About Evaxion

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Evaxion Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.10
$2.07
-29.23%
Oct 2026
$3.21
$2.92
-10.00%
Sep 2026
$2.97
$3.25
+2.52%
Aug 2026
$2.79
$3.17
+11.62%
Jul 2026
$3.06
$2.84
-9.55%
Jun 2026
$3.85
$3.14
-23.79%
May 2026
$4.48
$4.12
-3.51%
Apr 2026
$3.73
$4.27
+19.94%
Mar 2026
$3.20
$3.56
+10.22%
Feb 2026
$3.15
$3.23
+2.22%
Jan 2026
$4.84
$3.16
-34.30%
Dec 2025
$5.54
$4.81
-19.83%

Evaxion Share Price FAQs